Results 111 to 120 of about 14,367,683 (357)

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

Effect of chemotherapy on passenger mutations in metastatic colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Changes in passenger mutation load and predicted immunotherapy response after chemotherapy treatment. Tumor cells rich with passenger mutations have increased sensitivity to chemotherapy. Correlation of passenger mutations with neoantigen load suggests highly mutated clones promote a more effective response to immunotherapy, and therefore, first‐line ...
Marium T. Siddiqui   +6 more
wiley   +1 more source

A cooperative control strategy for power quality based on parallel grid-connected converters

open access: yes电力工程技术
Power quality control based on grid-connected converter can effectively utilize the surplus capacity of the converter and improves the benefits. However, existing methods tend to only consider grid-following (GFL) control and fail to fully utilize the ...
LIANG Xiaorui   +5 more
doaj   +1 more source

Power Quality

open access: yes, 2011
Electrical power is becoming one of the most dominant factors in our society. Power generation, transmission, distribution and usage are undergoing signifi cant changes that will aff ect the electrical quality and performance needs of our 21st century industry.
openaire   +3 more sources

Power quality and modern energy for all [PDF]

open access: bronze, 2019
Veronica Jacome   +5 more
openalex   +1 more source

Power Quality Disturbance Tracking Based on a Proprietary FPGA Sensor with GPS Synchronization [PDF]

open access: gold, 2021
Oscar N. Pardo-Zamora   +5 more
openalex   +1 more source

Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies

open access: yesMolecular Oncology, EarlyView.
We developed and validated a DNA methylation–based biomarker panel to distinguish pleural mesothelioma from other pleural conditions. Using the IMPRESS technology, we translated this panel into a clinically applicable assay. The resulting two classifier models demonstrated excellent performance, achieving high AUC values and strong diagnostic accuracy.
Janah Vandenhoeck   +12 more
wiley   +1 more source

Detection of circulating tumor DNA in colorectal cancer patients using a methylation‐specific droplet digital PCR multiplex

open access: yesMolecular Oncology, EarlyView.
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto   +8 more
wiley   +1 more source

Performance evaluation of instrument transformers in power quality measurements: activities and results from 19NRM05 IT4PQ project [PDF]

open access: green, 2023
G. Crotti   +17 more
openalex   +1 more source

Home - About - Disclaimer - Privacy